Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $15.6 million of Shares

- By insider

CEO & President of Vertex Pharmaceuticals Inc (VRTX) Jeffrey M Leiden sold 99,563 shares of VRTX on 01/16/2018 at an average price of $156.99 a share. The total sale was $15.6 million.

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Vertex Pharmaceuticals Inc has a market cap of $39.7 billion; its shares were traded at around $156.99 with a P/E ratio of 201.26 and P/S ratio of 17.02.


CEO Recent Trades:

  • CEO & President Jeffrey M Leiden sold 99,563 shares of VRTX stock on 01/16/2018 at the average price of $156.99. The price of the stock has decreased by 0% since.

CFO Recent Trades:

  • CFO Thomas Graney sold 777 shares of VRTX stock on 01/02/2018 at the average price of $149.95. The price of the stock has increased by 4.69% since.

Directors and Officers Recent Trades:

  • EVP, Global Research and CSO David Altshuler sold 56,250 shares of VRTX stock on 01/16/2018 at the average price of $156.99. The price of the stock has decreased by 0% since.

  • EVP, COO Ian F Smith sold 2,125 shares of VRTX stock on 01/16/2018 at the average price of $157.29. The price of the stock has decreased by 0.19% since.

  • EVP GMDA, CMO Jeffrey Chodakewitz sold 1,719 shares of VRTX stock on 01/16/2018 at the average price of $157.28. The price of the stock has decreased by 0.18% since.

  • EVPChief Commercial Officer Stuart A Arbuckle sold 2,125 shares of VRTX stock on 01/16/2018 at the average price of $158.28. The price of the stock has decreased by 0.82% since.

  • EVP, CL&AO Michael Parini sold 2,125 shares of VRTX stock on 01/12/2018 at the average price of $157.16. The price of the stock has decreased by 0.11% since.

For the complete insider trading history of VRTX, click here

.This article first appeared on GuruFocus.


Advertisement